What is Nuvation Bio's total?

Nuvation Bio (NUVB) reported total of $460.68M in Q4 2025.

How has Nuvation Bio's total changed year-over-year?

Nuvation Bio's total decreased by 3.7% year-over-year, from $478.48M to $460.68M.

What is the long-term trend for Nuvation Bio's total?

Over 5 years (2020 to 2025), Nuvation Bio's total has grown at a 18.8% compound annual growth rate (CAGR), from $194.84M to $460.68M.

Nuvation Bio NUVB Total

Total at other companies

Arcus BiosciencesRCUS

——

Tango TherapeuticsTNGX

——

Nektar TherapeuticsNKTR

——

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.25B+150%

Enterprise value$2.18B+154%

P/S15.7×-66.3×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's total?: Nuvation Bio (NUVB) reported total of $460.68M in Q4 2025.
How has Nuvation Bio's total changed year-over-year?: Nuvation Bio's total decreased by 3.7% year-over-year, from $478.48M to $460.68M.
What is the long-term trend for Nuvation Bio's total?: Over 5 years (2020 to 2025), Nuvation Bio's total has grown at a 18.8% compound annual growth rate (CAGR), from $194.84M to $460.68M.